IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.010
-0.005 (-0.49%)
At close: Jun 27, 2025, 4:00 PM
1.000
-0.010 (-0.99%)
After-hours: Jun 27, 2025, 7:59 PM EDT
IceCure Medical Revenue
IceCure Medical had revenue of $725.00K in the quarter ending March 31, 2025, a decrease of -2.42%. This brings the company's revenue in the last twelve months to $3.27M, up 0.34% year-over-year. In the year 2024, IceCure Medical had annual revenue of $3.29M with 1.92% growth.
Revenue (ttm)
$3.27M
Revenue Growth
+0.34%
P/S Ratio
15.56
Revenue / Employee
$49,591
Employees
66
Market Cap
59.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.29M | 62.00K | 1.92% |
| Dec 31, 2023 | 3.23M | 144.00K | 4.67% |
| Dec 31, 2022 | 3.09M | -1.05M | -25.45% |
| Dec 31, 2021 | 4.14M | 270.00K | 6.98% |
| Dec 31, 2020 | 3.87M | 2.21M | 132.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ICCM News
- 3 days ago - IceCure Announces Record Date for Rights Offering for Up to $10 Million - PRNewsWire
- 19 days ago - IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes - PRNewsWire
- 4 weeks ago - IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - IceCure Medical Reports First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 - PRNewsWire
- 7 weeks ago - IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation - PRNewsWire
- 2 months ago - IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer - PRNewsWire
- 2 months ago - IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - PRNewsWire